|
DPM1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.638400E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.620600E-04 |
| Normal-vs-Stage2 |
1.965950E-01 |
| Normal-vs-Stage3 |
2.538700E-03 |
| Normal-vs-Stage4 |
3.997600E-02 |
| Stage1-vs-Stage2 |
3.994400E-01 |
| Stage1-vs-Stage3 |
6.173200E-01 |
| Stage1-vs-Stage4 |
4.670600E-01 |
| Stage2-vs-Stage3 |
3.102400E-01 |
| Stage2-vs-Stage4 |
7.754800E-01 |
| Stage3-vs-Stage4 |
3.429400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.634700E-04 |
| Normal-vs-AfricanAmerican |
1.722480E-02 |
| Normal-vs-Asian |
3.402200E-01 |
| Caucasian-vs-AfricanAmerican |
6.388400E-01 |
| Caucasian-vs-Asian |
7.598000E-01 |
| AfricanAmerican-vs-Asian |
8.278400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.167300E-04 |
| Normal-vs-Female |
8.502200E-03 |
| Male-vs-Female |
2.900800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.344100E-03 |
| Normal-vs-Age(41-60Yrs) |
5.369600E-04 |
| Normal-vs-Age(61-80Yrs) |
3.258800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.191700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.032400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.322400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.829600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.336200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.522200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.580400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.107200E-01 |
| Normal-vs-Grade 2 |
1.989770E-02 |
| Normal-vs-Grade 3 |
3.77440000000062E-05 |
| Normal-vs-Grade 4 |
4.102900E-03 |
| Grade 1-vs-Grade 2 |
9.207400E-01 |
| Grade 1-vs-Grade 3 |
1.444590E-01 |
| Grade 1-vs-Grade 4 |
3.084600E-01 |
| Grade 2-vs-Grade 3 |
3.814100E-02 |
| Grade 2-vs-Grade 4 |
2.639000E-01 |
| Grade 3-vs-Grade 4 |
8.152200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.623700E-03 |
| Normal-vs-ccB subtype |
6.195900E-03 |
| ccA subtype-vs-ccB subtype |
8.647200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.604400E-03 |
| Normal-vs-N1 |
2.052800E-01 |
| N0-vs-N1 |
8.086200E-01 |
|
|
